CARBOPLATIN for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 3,487 adverse event reports in the FDA FAERS database where CARBOPLATIN was used for Lung neoplasm malignant.
Most Reported Side Effects for CARBOPLATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 6,100 | 7.3% | 957 | 2,160 |
| Neutropenia | 5,314 | 6.3% | 672 | 1,919 |
| Anaemia | 5,312 | 6.3% | 592 | 2,761 |
| Febrile neutropenia | 4,888 | 5.8% | 846 | 3,033 |
| Nausea | 4,588 | 5.5% | 489 | 2,306 |
| Disease progression | 4,538 | 5.4% | 1,159 | 618 |
| Thrombocytopenia | 4,483 | 5.3% | 604 | 1,928 |
| Malignant neoplasm progression | 4,177 | 5.0% | 1,068 | 971 |
| Diarrhoea | 4,154 | 4.9% | 583 | 2,581 |
| Dyspnoea | 3,494 | 4.2% | 463 | 1,867 |
| Drug ineffective | 3,377 | 4.0% | 854 | 802 |
| Vomiting | 3,303 | 3.9% | 439 | 2,027 |
| Pyrexia | 3,116 | 3.7% | 352 | 2,297 |
| Pancytopenia | 2,910 | 3.5% | 563 | 1,921 |
| Fatigue | 2,857 | 3.4% | 356 | 1,235 |
Other Indications for CARBOPLATIN
Non-small cell lung cancer (7,939)
Ovarian cancer (5,850)
Product used for unknown indication (5,003)
Breast cancer (4,036)
Lung adenocarcinoma (3,888)
Triple negative breast cancer (3,195)
Small cell lung cancer (1,991)
Chemotherapy (1,902)
Diffuse large b-cell lymphoma (1,843)
Non-small cell lung cancer metastatic (1,629)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)
ATEZOLIZUMAB (1,262)